RAY B logo

RaySearch Laboratories AB (publ) Stock Price

OM:RAY B Community·SEK 8.4b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 15 Fair Values set on narratives written by author

RAY B Share Price Performance

SEK 245.00
87.40 (55.46%)
32.9% undervalued intrinsic discount
SEK 365.00
Fair Value
SEK 245.00
87.40 (55.46%)
32.9% undervalued intrinsic discount
SEK 365.00
Fair Value
Price SEK 245.00
AnalystConsensusTarget SEK 365.00

RAY B Community Narratives

AnalystConsensusTarget·
Fair Value SEK 365 32.9% undervalued intrinsic discount

Aging Population And AI Integration Will Expand Oncology Market

0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative

Recent RAY B News & Updates

RaySearch Laboratories (STO:RAY B) Shareholders Will Want The ROCE Trajectory To Continue

Sep 28
RaySearch Laboratories (STO:RAY B) Shareholders Will Want The ROCE Trajectory To Continue

RaySearch Laboratories AB (publ) (STO:RAY B) Stocks Pounded By 26% But Not Lagging Market On Growth Or Pricing

Aug 19
RaySearch Laboratories AB (publ) (STO:RAY B) Stocks Pounded By 26% But Not Lagging Market On Growth Or Pricing

At kr344, Is It Time To Put RaySearch Laboratories AB (publ) (STO:RAY B) On Your Watch List?

Jul 07
At kr344, Is It Time To Put RaySearch Laboratories AB (publ) (STO:RAY B) On Your Watch List?

RaySearch Laboratories (STO:RAY B) Is Paying Out A Larger Dividend Than Last Year

May 23
RaySearch Laboratories (STO:RAY B) Is Paying Out A Larger Dividend Than Last Year

RaySearch Laboratories AB (publ) Key Details

SEK 1.3b

Revenue

SEK 107.0m

Cost of Revenue

SEK 1.1b

Gross Profit

SEK 952.6m

Other Expenses

SEK 193.0m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Nov 07, 2025
Earnings per share (EPS)
5.63
Gross Margin
91.46%
Net Profit Margin
15.41%
Debt/Equity Ratio
0%

RaySearch Laboratories AB (publ) Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Flawless balance sheet with high growth potential.

0 Risks
2 Rewards

About RAY B

Founded
2000
Employees
431
CEO
Johan Lof
WebsiteView website
www.raysearchlabs.com

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. The company offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems. It also provides µ-RayStation* (Micro-RayStation), a software platform for planning and evaluation in small animal irradiation research; RayPlan, a treatment planning system; DrugLog, which verifies the identity and concentration of compounded injectables before administered to a patient; RayMigrate, allows users to convert Pinnacle patient data to RayStation format and/or to DICOM format; and machine learning and liver ablation solutions. It has collaboration with Vision RT for integration of MapRT with RayStation treatment planning system. The company was founded in 2000 and is headquartered in Stockholm, Sweden.

Market Insight

Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading

Swedish Market Performance

  • 7 Days: -1.1%
  • 3 Months: 1.8%
  • 1 Year: -1.3%
  • Year to Date: 2.0%
Over the last 7 days, the market has dropped 1.1%, driven by a loss of 1.7% in the Industrials sector. Overall the market has been flat in the last year. Looking forward, earnings are forecast to grow by 16% annually. Market details ›